share_log

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $57 Price Target

HC Wainwright & Co. Reiterates Buy on Pacira BioSciences, Maintains $57 Price Target

HC Wainwright & Co.重申买入Pacira BioSciences,维持57美元的目标股价
Moomoo 24/7 ·  03/04 07:02

HC Wainwright & Co. analyst Oren Livnat reiterates Pacira BioSciences (NASDAQ:PCRX) with a Buy and maintains $57 price target.

HC Wainwright & Co. 分析师奥伦·利夫纳特重申了帕西拉生物科学(纳斯达克股票代码:PCRX)的买入并维持57美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发